Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform
- 18 March 2009
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (9), 2456-2460
- https://doi.org/10.1016/j.bmcl.2009.03.051
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- 2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: Optimization via array synthesisBioorganic & Medicinal Chemistry Letters, 2008
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsNew England Journal of Medicine, 2007
- Tetrazole and ester substituted tetrahydoquinoxalines as potent cholesteryl ester transfer protein inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Potential New Approach for Treating Coronary Artery DiseaseJournal of Medicinal Chemistry, 2005
- Dibenzodioxocinones—A new class of CETP inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Discovery of a Simple Picomolar Inhibitor of Cholesteryl Ester Transfer ProteinJournal of Medicinal Chemistry, 2003
- Bis(2-(Acylamino)phenyl) Disulfides, 2-(Acylamino)benzenethiols, and S-(2-(Acylamino)phenyl) Alkanethioates as Novel Inhibitors of Cholesteryl Ester Transfer ProteinJournal of Medicinal Chemistry, 2000
- Dichloroborane-dimethyl sulfide, a highly selective reducing agent for reduction of organyl azides to aminesTetrahedron Letters, 1995
- New approaches to atherosclerosis: An overviewMedicinal Research Reviews, 1993
- Decarbalkoxylation of isohexylmalonatesThe Journal of Organic Chemistry, 1977